Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX10+Chemotherapy
Non-Small-Cell Lung Cancer
Phase III
A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
HLX10+HLX04
Advanced Malignant Solid Tumor
Phase I

A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Anti-PD-1 Antibody (HLX10) in Combination with Avastin Biosimilar (HLX04) in Patients with Advanced Solid Tumors

HLX10+HLX04
Hepatocellular Carcinoma
Phase II
A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients With Disease Progression or Intolerant Toxicity After Standard Treatment
HLX10
Advanced Solid Tumors
Phase I Phase I Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients with Advanced Solid Tumors
HLX10
Gastric Cancer
Phase III
A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer